Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Acorda Therapeutics Inc    ACOR   US00484M1062

Delayed Quote. Delayed Nasdaq - 04/24 03:48:23 pm
35.12 USD   -0.37%
2d ago ACORDA THERAPEUTICS : Other Events (form 8-K)
04/14DJHOT STOCKS : Hot Stocks to Watch
04/14 ACORDA THERAPEUTICS : Other Events (form 8-K)
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/17/2014 04/21/2014 04/22/2014 04/23/2014 04/24/2014 Date
34.62(c) 35.09(c) 35.77(c) 35.25(c) 35.12 Last
365 300 378 025 462 660 311 033 148 077 Volume
-2.04% +1.36% +1.94% -1.45% -0.37% Change
More quotes
Company
Acorda Therapeutics, Inc. engages in the identification, development and commercialization of novel therapies that improve neurological function in people with multiple sclerosis, spinal cord injury and other disorders of the nervous system. The company's two main products are Ampyra and Zanaflex... 
Sector
Biotechnology
Calendar
08/05Earnings Release
Surperformance© rating of Acorda Therapeutics Inc
Trading Rating : Investor Rating :
More about the company
Chart ACORDA THERAPEUTICS INC
Duration : Period :
Acorda Therapeutics Inc Technical Analysis Chart | ACOR | US00484M1062 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 365 M
EBIT 2014 33,8 M
Net income 2014 21,1 M
Debt 2014 228 M
Yield 2014 -
Sales 2015 413 M
EBIT 2015 53,8 M
Net income 2015 32,3 M
Debt 2015 -
Yield 2015 -
PER 2014 71,67
PER 2015 46,27
Capi. / Sales 2014 4,68x
Capi. / Sales 2015 3,57x
Capitalization 1 478 M
More Financials
Latest news on ACORDA THERAPEUTICS INC
2d ago ACORDA THERAPEUTICS : Other Events (form 8-K)
04/14DJHOT STOCKS : Hot Stocks to Watch
04/14 ACORDA THERAPEUTICS : Other Events (form 8-K)
04/11 ACORDA THERAPEUTICS : to Expand Corporate Footprint in Ardsley
04/02 ACORDA THERAPEUTICS : Patent Issued for Methods of Reducing Extravasation of Inf..
04/01 ACORDA THERAPEUTICS : Assigned Patent
03/26 ACORDA THERAPEUTICS : Joins Participants from Around the World in Recognizing Pu..
03/12 ACORDA THERAPEUTICS : Patent Issued for Sustained Release Aminopyridine Composit..
03/10 ACORDA THERAPEUTICS INC : Acorda Therapeutics Assigned Patent
03/05 ACORDA THERAPEUTICS INC : Acorda Therapeutics to Present at the Cowen & Company ..
02/26 ACORDA THERAPEUTICS INC : Acorda Therapeutics to Present at the Cowen & Company ..
02/19 ACORDA THERAPEUTICS INC : Acorda Therapeutics Reports Fourth Quarter and Full Ye..
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishBullishNeutral
Technical analysis
Income Statement Evolution
Acorda Therapeutics Inc : Income Statement Evolution
More Financials
EPS Revisions
Acorda Therapeutics Inc : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF